熱門資訊> 正文
Nasus Pharma Ltd.报告财年业绩
2026-03-25 21:17
- Nasus Pharma Ltd. press release (NSRX): FY Cash, Cash Equivalents and Marketable Securities: As of December 31, 2025, Nasus had cash, cash equivalents and marketable securities of $4.3 million, compared with cash and cash equivalents of $0.3million as of December 31, 2024.
- For the year ended December 31, 2025, net loss was $5.9 million compared with a net loss of $1.5 million for the year ended December 31, 2024.
- "Following our $15 private placement, which closed in February 2026, Nasus expects that its cash, cash equivalents and marketable securities will be sufficient to fund its operations through the second quarter of 2027."
More on Nasus Pharma Ltd.
- Nasus Pharma prices $15M private placement
- Historical earnings data for Nasus Pharma Ltd.
- Financial information for Nasus Pharma Ltd.
推薦文章
美股機會日報 | 伊朗放話已關閉霍爾木茲海峽！國際油價應聲走高；特朗普何時結束戰爭？巴克萊點出「五大關鍵信號」
一周IPO | 賺錢效應爆棚！本周八隻新股暗盤齊漲；馬斯克擬將SpaceX30%新股分給散户
地緣衝突倒逼能源革命！美伊衝突下新能源價值再重估，港美股新能源該怎麼配置？
美股機會日報 | 決戰將至？美方密謀對伊發動「致命一擊」！谷歌新技術引發存儲需求擔憂！分析師「寬心」稱需求將不降反增
美股機會日報 | 特朗普再放豪言！正與伊朗談判，並收到伊方「大禮」；特斯拉機器人再迎新進展！馬斯克稱有望明年實現量產
一圖看懂 | 單季盈利承壓！拼多多Q4營收1239億元同比增12%，調后淨利卻下跌12%；高管稱「力爭三年再造一個拼多多」
財報前瞻 | 美團Q4財報將放榜！大摩、高盛逆勢力挺股價，當前美團已嚴重超跌？
美股機會日報 | 中東硝煙將散？以官員稱美方4月9日結束對伊戰爭！海力士擬籌資百億赴美上市，豪擲80億美元鎖定阿斯麥光刻機！
風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。
